BRIDGEWAY CAPITAL MANAGEMENT, LLC - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 36 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q4 2021$20,000
-41.2%
74,3000.0%0.00%
-100.0%
Q3 2021$34,000
-24.4%
74,3000.0%0.00%0.0%
Q2 2021$45,000
-40.0%
74,300
-32.0%
0.00%0.0%
Q1 2021$75,000
+78.6%
109,3000.0%0.00%0.0%
Q4 2020$42,000
-19.2%
109,3000.0%0.00%0.0%
Q3 2020$52,000
-7.1%
109,3000.0%0.00%0.0%
Q2 2020$56,000109,3000.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 960,680$655,0000.02%
Virtu Financial LLC 466,704$318,0000.02%
tru Independence LLC 60,000$30,0000.01%
Jacobi Capital Management LLC 18,500$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,300$75,0000.00%
Focused Wealth Management, Inc 500$00.00%
UBS Group AG 576,927$393,0000.00%
Stratos Wealth Partners, LTD. 10,850$7,0000.00%
NewEdge Advisors, LLC 14,187$10,0000.00%
Sowell Financial Services LLC 74$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders